The Indianapolis Colts are at the center of a shocking revelation: the FBI has initiated an investigation into the death of their former owner, Jim Irsay, and the role of a California doctor who allegedly prescribed him painkillers and ketamine. This news, first reported by The Washington Post, has sent ripples through the NFL community and beyond.
But here's where it gets intriguing: while the Colts acknowledge the investigation, they claim the FBI hasn't contacted them directly, and no subpoenas have been issued. This raises questions about the nature and scope of the probe. Irsay, a prominent figure in the NFL, passed away in May 2026 at the age of 65 due to cardiac arrest, according to reports.
The Washington Post's story reveals that the FBI is seeking records and information related to Irsay's death, substance use, and his association with Dr. Harry Haroutunian, a California-based addiction specialist. The Post's sources indicate that a grand jury subpoena was issued in Los Angeles this month, and individuals close to Irsay have been contacted.
Irsay's death at the Beverly Hills Hotel, where Dr. Haroutunian was also staying and treating Irsay, adds a layer of complexity. Irsay had been open about his struggles with substance abuse, including multiple overdoses. His daughters have now taken over ownership of the Colts, leaving many to wonder about the potential impact of this investigation on the team's future.
And this is the part that might spark debate: Could this investigation lead to a deeper examination of the NFL's approach to player health and substance abuse issues? How might it affect the Colts organization and the NFL's relationship with medical professionals? Share your thoughts below, but remember to keep the discussion respectful and insightful.
